|Bid price||300.00||Open price||287.50|
|Ask price||315.00||Prev close||315.00|
Register now for FREE live Immunodiagnostic Systems Holdings share prices, Immunodiagnostic Systems Holdings stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Immunodiagnostic Systems Holdings Level 2 Data, indepth research tools and investor commentary for Immunodiagnostic Systems Holdings (IDH) and other London Stock Exchange equities.
Register now for FREE Immunodiagnostic Systems Holdings share price charts
|Name||Immunodiagnostic Systems Holdings||Epic||IDH|
|Sector||Health Care Equipment & Services||ISIN||GB00B01YZ052|
|Activites||Immunodiagnostic Systems Limited (IDS) is a dynamic company, an SME, dedicated to the development and provision of innovative assays for use in clinical and research laboratories worldwide. From a modest Sales and Distribution operation established in 1977, IDS has become not only a developer and manufacturer in its own right, but also nurtures technology development externally, in British universities and research institutes. The Company is focussed on sustaining its position as a fully integrated In Vitro Diagnostics (IVD) company, building and maintaining capability in de novo product design, development, manufacture and global marketing.||Index||n/a|
|Latest Share Price (p)||315.00||Net Gearing (%)||-25.36|
|Market Capitalisation (£m)||86.04||Gross Gearing (%)||17.23|
|Shares in issue (m)||29.42||Debt Ratio||7.51|
|P/E Ratio||-2.67||Debt-to-Equity Ratio||0.39|
|Total dividends per share (p)||1.20||Assets / Equity Ratio||1.21|
|Dividend Yield (%)||0.41||Price to book value||1.67|
|Dividend cover (x)||6.07||ROCE (%)||-66.36|
|Earning per share (p)||-109.70||EPS Growth (%)||-1,454.32|
|52 week high / low||295.00 / 112.50||DPS Growth (%)||-60.00|
|Dec.Date||Type||Director||Pos||No. of Shares|
Immunodiagnostic Systems Holdings expects revenue for the year ended 31 March to be approximately £40m, an increase of around 4% compared to the previous year. It said revenue had been favourably impacted by the weakening of the pound against the euro and US dollar. At constant exchange...
Story provided by StockMarketWire.com
RNS Number : 9207C Immunodiagnostic Systems Hldgs PLC 21 April 2017 Trading Update Immunodiagnosti c System s Holding s PLC 21 April 2017 Immunodiagnosti c System s Holding s plc Trading Update for the year...
Register now for FREE Immunodiagnostic Systems Holdings company news
Immunodiagnostic Systems Holdings has warned that revenues for the year to March are likely to be lower than current market forecasts. It said revenues for the nine months to December were Â£39.6m, compared to Â£35.4m for the comparable period in 2010 but as a consequence of the trading...
Register now for FREE Immunodiagnostic Systems Holdings share price discussions